Prospective, Open-labelled, Phase II Study, of the Administration of Desmopressin in Patients With Colorectal Cancer, With or Without Metastasis, With Rectal Bleeding, Before Treatment With Surgery and/or Chemotherapy and/or Radiotherapy.
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2017
At a glance
- Drugs Desmopressin (Primary)
- Indications Colorectal cancer; Rectal bleeding
- Focus Adverse reactions
- Sponsors Elea
- 06 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Mar 2017.
- 01 Aug 2016 Planned End Date changed from 1 Dec 2016 to 1 Mar 2017.
- 01 Aug 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2016.